(S)-2,6-Diaminohexanamide dihydrochloride is primarily utilized in biochemical research and pharmaceutical development. It serves as a key intermediate in the synthesis of various bioactive compounds, particularly those targeting neurological and metabolic disorders. Its chiral nature makes it valuable in the production of enantiomerically pure drugs, enhancing their efficacy and reducing side effects. Additionally, it is employed in peptide synthesis, where it acts as a building block for creating specific amino acid sequences. This compound is also explored in studies related to enzyme inhibition and receptor binding, contributing to the development of novel therapeutic agents.